New report highlights progress and persistent gaps in global viral hepatitis elimination, underscoring need to expand testing ...
Hosted on MSN
How Is Liver Disease Treated?
Liver disease is a condition that affects the health and function of the liver. The liver is a hard-working organ that helps digest foods and process nutrients, filters and removes waste from the body ...
Cholestatic liver diseases and autoimmune hepatitis represent complex, immune‐mediated conditions that culminate in progressive hepatic injury. Disorders such as primary sclerosing cholangitis, ...
Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone for ...
Blood tests can help with the diagnosis of autoimmune hepatitis. These include tests for increased liver enzymes or antibody levels. However, other tests are necessary to confirm the diagnosis.
Familial hypobetalipoproteinemia (FHBL), caused by apolipoprotein B (APOB) variants, disrupts APOB-containing lipoprotein ...
News-Medical.Net on MSN
Myosteatosis: An emerging predictor of outcomes in chronic liver disease
Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...
A person with liver disease symptoms should talk with a doctor to determine the best treatment. Early treatment can often stop or slow the progression of liver disease and improve a person’s quality ...
Myosteatosis is associated with poor outcomes in various liver diseases. However, standardized methods for assessing, defining, and diagnosing myosteatosis in the context of liver diseases remain ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results